Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3851-3864
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3851
Figure 1
Figure 1 Retrospective analysis flowchart for hepatocellular carcinoma patients with human immunodeficiency virus infection after hepatectomy. HCC: Hepatocellular carcinoma; HIV: Human immunodeficiency virus; OS: Overall survival; DFS: Disease-free survival.
Figure 2
Figure 2 Differences in survival and prognosis between the surgical group and nonsurgical group. HCC: Hepatocellular carcinoma; HIV: Human immunodeficiency virus; OS: Overall survival.
Figure 3
Figure 3 Overall survival (human immunodeficiency virus) survival analysis of patients in the hepatocellular carcinoma-human immunodeficiency virus surgery group. HIV: Human immunodeficiency virus; HCC: Hepatocellular carcinoma; OS: Overall survival; DFS: Disease-free survival.
Figure 4
Figure 4 Factors influencing patient overall survival (human immunodeficiency virus). HIV: Human immunodeficiency virus; HCC: Hepatocellular carcinoma; MSM: Men who have sex with men; MVI: Microvascular invasion; OS: Overall survival.
Figure 5
Figure 5 Factors influencing patient disease-free survival. HIV: Human immunodeficiency virus; HCC: Hepatocellular carcinoma; MSM: Men who have sex with men; MVI: Microvascular invasion; DFS: Disease-free survival.